Elekta makes products to help in the treatment of cancer and brain disorders. Specifically, it develops products for radiation therapy, radiosurgery, and brachytherapy.

Last year, the Swedish company's share price dropped 19%, to 79.70 Swedish Krona ($11.48) from 98.35 Swedish Krona ($15.43) at the end of 2013. As a result, $1.6 billion was wiped out from its market cap.